Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
Blocking a specific protein with a little-known, experimental drug restored balance in the immune systems of lab mice, preventing them from developing multiple sclerosis, researchers at San Francisco's Gladstone Institutes found.
Researchers from the Gladstone Institutes have discovered that astrocytes - typically thought of as "helper" cells in the brain - are involved in forgetting, and too many of these cells may contribute to Alzheimer's disease. The researchers are now working to repurpose old drugs used for Parkinson's disease and epilepsy to use as new therapies to treat memory loss in Alzheimer's.
Gladstone Institutes postdoctoral fellow Casey Gifford, PhD, was awarded the Damon Runyon Cancer Research Foundation Fellowship to study DNA-binding proteins in order to understand how a disruption in the expression of these proteins can lead to cancer.
The antiretroviral drug Truvada is most effective at reducing the risk of infection when taken daily. But used before and after sex, as directed, PReP also significantly lessened the risk of HIV transmission.
Scientists have long thought that HIV's tendency to lay dormant within a person for 10 years or more was due to the behavior of the cells it infects or an error in the disease’s programming, but new evidence suggests that this inactivity may be an evolutionary strategy to help the virus to survive and spread.
Early research by Dr. Katherine Pollard identified many regions of the human genome that appear to be evolving quickly. New research suggests these areas are responsible for differentiating human brains from chimpanzee brains.
Dr. Katherine Pollard comments on new research that investigates how super-evolving parts of our genome differentiated our brains from chimpanzees'. Dr. Pollard was one of the first researchers to identify these special genome sequences, dubbed "human-accelerated regions."
Dr. Katherine Pollard says it's easy to find genetic differences between humans and chimpanzees, but it's hard to know precisely what these differences are doing. In Dr. Pollard's lab, scientists are exploring human and chimp DNA with stem cells in a dish and are using genome engineering to study the effects of these differences.
Dr. Sheng Ding is working to develop a drug that can convert energy-storing white fat into calorie-burning brown fat. He says this could help improve weight loss and treat obesity or diabetes.
This month, the Gladstone Institutes in San Francisco reported a chemical trick that substantially increases the efficiency of gene editing using CRISPR technology.